Orth S R, Weinreich T, Bönisch S, Weih M, Ritz E
Department Internal Medicine, Ruperto Carola University, Heidelberg, Germany.
Exp Nephrol. 1995 Jan-Feb;3(1):23-33.
Several experimental studies point to a potential role of angiotensin II (Ang II) in the progression of glomerulosclerosis even in the absence of glomerular hypertension. We tested the hypothesis that Ang II acts as a growth factor for adult human mesangial cells (AHMC). AHMC were isolated from noninvolved parts of tumor nephrectomy specimens and grown in RPMI medium with the addition of fetal calf serum (FCS). All studies were performed with growth-arrested cells. Proliferation studies were done in serum-free standard growth medium (SF) with the addition of either various concentrations of insulin, plasma-derived serum, or FCS. Ang II (10(-10) to 10(-6) M) dose dependently increased the 3H-thymidine uptake of AHMC up to 57 +/- 13% over solvent controls (p < 0.01). In parallel, the DNA content was 36 +/- 10% higher (p < 0.05) than in solvent controls after 2 days of culture. The cell numbers were higher up to 47 +/- 8% in Ang II (10(-6) M) stimulated cultures after 4 days of incubation (p < 0.01). The effect of Ang II was specific, since it was almost completely obliterated by the AT1 receptor antagonist DuP753. The effect of Ang II was particularly marked when cultures were incubated with SF plus high concentrations (1.7 x 10(-6) M) of insulin or SF plus 10% plasma-derived serum. In contrast, the effect was not significant when cultures were incubated with SF plus 10% FCS. Ang II, when added to platelet-derived growth factor at various concentrations, did not further increase the proliferation. The effect on protein synthesis was assessed in growth-arrested AHMC by 3H-methionine uptake and protein/DNA ratio in cell lysates. Ang II (10(-10) to 10(-6) M) dose dependently increased the 3H-methionine uptake of AHMC up to 47 +/- 10% over solvent controls (p < 0.01). In parallel Ang II (10(-8) to 10(-6) M) dose dependently increased the 3H-methionine uptake of the protein/DNA ratio by 24 +/- 6% after 48 h of incubation. DuP753 obliterated the stimulatory effect of Ang II. Ang II (10(-6) M) also increased the mRNA of the immediate-early growth-related gene Egr-1. We conclude that Ang II induces hypertrophy and proliferation in adult human mesangial cells. This result is of interest with respect to a potential role of Ang II in the pathogenesis of glomerulosclerosis in humans.
多项实验研究表明,即使在不存在肾小球高血压的情况下,血管紧张素II(Ang II)在肾小球硬化进展中也可能发挥作用。我们检验了Ang II作为成人肾小球系膜细胞(AHMC)生长因子的假说。AHMC取自肿瘤肾切除标本的未受累部分,并在添加胎牛血清(FCS)的RPMI培养基中培养。所有研究均使用生长停滞的细胞进行。增殖研究在无血清标准生长培养基(SF)中进行,添加不同浓度的胰岛素、血浆来源血清或FCS。Ang II(10^(-10)至10^(-6) M)剂量依赖性地使AHMC的3H-胸腺嘧啶核苷摄取量比溶剂对照增加高达57±13%(p<0.01)。同时,培养2天后,DNA含量比溶剂对照高36±10%(p<0.05)。孵育4天后,在Ang II(10^(-6) M)刺激的培养物中细胞数量最多增加47±8%(p<0.01)。Ang II的作用具有特异性,因为它几乎完全被AT1受体拮抗剂DuP753消除。当培养物与添加高浓度(1.7×10^(-6) M)胰岛素的SF或添加10%血浆来源血清的SF一起孵育时,Ang II的作用尤为明显。相比之下,当培养物与添加10% FCS的SF一起孵育时,该作用不显著。Ang II与不同浓度的血小板衍生生长因子一起添加时,不会进一步增加增殖。通过3H-甲硫氨酸摄取和细胞裂解物中的蛋白质/DNA比值评估对生长停滞的AHMC蛋白质合成的影响。Ang II(10^(-10)至10^(-6) M)剂量依赖性地使AHMC的3H-甲硫氨酸摄取量比溶剂对照增加高达47±10%(p<0.01)。同时,孵育48小时后,Ang II(10^(-8)至10^(-6) M)剂量依赖性地使蛋白质/DNA比值的3H-甲硫氨酸摄取量增加24±6%。DuP753消除了Ang II的刺激作用。Ang II(10^(-6) M)还增加了早期生长相关基因Egr-1的mRNA。我们得出结论,Ang II诱导成人肾小球系膜细胞肥大和增殖。这一结果对于Ang II在人类肾小球硬化发病机制中的潜在作用具有重要意义。